# PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma

> **NCT01939665** · PHASE1,PHASE2 · COMPLETED · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 50 (estimated)

## Conditions studied

- Locally Advanced Pancreatic Carcinoma (LAPC)
- Non-metastasized Unresectable Pancreatic Carcinoma
- Pancreatic Cancer

## Interventions

- **DEVICE:** NanoKnife "Irreversible electroporation (IRE)"

## Key facts

- **NCT ID:** NCT01939665
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939665, "PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01939665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*